2021
DOI: 10.1021/jacs.1c08181
|View full text |Cite
|
Sign up to set email alerts
|

Machine-Learning-Guided Discovery of 19F MRI Agents Enabled by Automated Copolymer Synthesis

Abstract: Modern polymer science suffers from the curse of multidimensionality. The large chemical space imposed by including combinations of monomers into a statistical copolymer overwhelms polymer synthesis and characterization technology and limits the ability to systematically study structure–property relationships. To tackle this challenge in the context of 19F magnetic resonance imaging (MRI) agents, we pursued a computer-guided materials discovery approach that combines synergistic innovations in automated flow s… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
96
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 94 publications
(109 citation statements)
references
References 114 publications
(174 reference statements)
1
96
0
Order By: Relevance
“… (B) Compositions of eight copolymer samples and their SNR values. The figure is reprinted with permission from ref ( Reis et al., 2021 ). Copyright 2021 American Chemical Society.…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations
“… (B) Compositions of eight copolymer samples and their SNR values. The figure is reprinted with permission from ref ( Reis et al., 2021 ). Copyright 2021 American Chemical Society.…”
Section: Resultsmentioning
confidence: 99%
“… The figure is reprinted with permission from ref ( Reis et al., 2021 ). Copyright 2021 American Chemical Society.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…However, the actual costs are generally a commercial con dential information and, therefore, such estimates may not fully capture the complete investments required 4 . The try-and-error approach to molecule development, particularly during the initial design and make phases of the design-make-test-analyse (DMTA) discovery cycle, is often is directed by human intuition, which is inherently biased and limited in knowledge, thus slowing drug development 5 . In such contest, the ability of data-driven in-silico prediction tools to model outcomes without the need to physically prepare candidates and run experiments would enable a fast throughput screening of candidate molecules and thus reducing both the time and monetary investments required to identify lead candidates [6][7][8][9] .…”
Section: Introductionmentioning
confidence: 99%